{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:44:53Z","timestamp":1761900293641,"version":"build-2065373602"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0508705"],"award-info":[{"award-number":["2023ZD0508705"]}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370593"],"award-info":[{"award-number":["82370593"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Municipal Health Commission Capital Health Development Research Project","award":["2022-1-2021"],"award-info":[{"award-number":["2022-1-2021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Nutr"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1186\/s12263-025-00779-4","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:15:55Z","timestamp":1761898555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of non-alcoholic fatty liver polygenic risk scores with the incident and progressive non-alcoholic fatty liver disease in Chinese population"],"prefix":"10.1186","volume":"20","author":[{"given":"Yang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenlu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shutong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengge","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"4","key":"779_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","volume":"1","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;1(4):1335\u201347. https:\/\/doi.org\/10.1097\/hep.0000000000000004.","journal-title":"Hepatology"},{"issue":"3","key":"779_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong VW, Ekstedt M, Wong GL, Hagstrom H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol Sep. 2023;79(3):842\u201352. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.036.","journal-title":"J Hepatol Sep"},{"issue":"4","key":"779_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"7","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut Mar. 2024;7(4):691\u2013702. https:\/\/doi.org\/10.1136\/gutjnl-2023-330595.","journal-title":"Gut Mar"},{"issue":"5","key":"779_CR4","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1053\/j.gastro.2009.01.050","volume":"136","author":"JB Schwimmer","year":"2009","unstructured":"Schwimmer JB, Celedon MA, Lavine JE, et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology. 2009;136(5):1585\u201392. https:\/\/doi.org\/10.1053\/j.gastro.2009.01.050.","journal-title":"Gastroenterology"},{"issue":"5","key":"779_CR5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","volume":"150","author":"RM Mancina","year":"2016","unstructured":"Mancina RM, Dongiovanni P, Petta S, et al. The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent. Gastroenterology 2016-05. 2016;150(5):1219\u2013e12306. https:\/\/doi.org\/10.1053\/j.gastro.2016.01.032.","journal-title":"Gastroenterology 2016-05"},{"key":"779_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2901","author":"J Kozlitina","year":"2014","unstructured":"Kozlitina J, Smagris E, Stender S, et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2014. https:\/\/doi.org\/10.1038\/ng.2901.","journal-title":"Nat Genet"},{"key":"779_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001324","volume":"2011","author":"EK Speliotes","year":"2011","unstructured":"Speliotes EK, Yerges-Armstrong LM, Wu J, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;2011:e1001324. https:\/\/doi.org\/10.1371\/journal.pgen.1001324.","journal-title":"PLoS Genet"},{"issue":"12","key":"779_CR8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"2008","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;2008(12):1461\u20135. https:\/\/doi.org\/10.1038\/ng.257.","journal-title":"Nat Genet"},{"issue":"4","key":"779_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/joim.12719","volume":"283","author":"P Dongiovanni","year":"2018","unstructured":"Dongiovanni P, Stender S, Pietrelli A, et al. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med. 2018;283(4):356\u201370. https:\/\/doi.org\/10.1111\/joim.12719.","journal-title":"J Intern Med"},{"key":"779_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","volume":"2021","author":"C Bianco","year":"2021","unstructured":"Bianco C, Jamialahmadi O, Pelusi S, et al. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. J Hepatol. 2021;2021:775\u201382. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.024.","journal-title":"J Hepatol"},{"issue":"7","key":"779_CR11","doi-asserted-by":"publisher","first-page":"100687","DOI":"10.1016\/j.xcrm.2022.100687","volume":"19","author":"DS Araujo","year":"2022","unstructured":"Araujo DS, Wheeler HE. Genetic and environmental variation impact transferability of polygenic risk scores. Cell Rep Med Jul. 2022;19(7):100687. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100687.","journal-title":"Cell Rep Med Jul"},{"issue":"4","key":"779_CR12","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/hep.32774","volume":"1","author":"TC Yip","year":"2023","unstructured":"Yip TC, Vilar-Gomez E, Petta S, et al. Geographical similarity and differences in the burden and genetic predisposition of NAFLD. Hepatology. 2023;1(4):1404\u201327. https:\/\/doi.org\/10.1002\/hep.32774.","journal-title":"Hepatology"},{"issue":"3","key":"779_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.102495","volume":"15","author":"M Souza","year":"2025","unstructured":"Souza M, Al-Sharif L, Diaz I, Mantovani A, Villela-Nogueira CA. Global epidemiology and implications of PNPLA3 I148M variant in metabolic dysfunction\u2013associated steatotic liver disease: a systematic review and meta-analysis. J Clin Exp Hepatol. 2025;(3):102495. https:\/\/doi.org\/10.1016\/j.jceh.2024.102495.","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"779_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/apt.16772","volume":"55","author":"M Xia","year":"2022","unstructured":"Xia M, Ma S, Huang Q, et al. NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study. Aliment Pharmacol Ther. 2022;55(6):705\u201321. https:\/\/doi.org\/10.1111\/apt.16772.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"779_CR15","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1002\/hep4.1976","volume":"2022","author":"CE Thomas","year":"2022","unstructured":"Thomas CE, Diergaarde B, Kuipers AL, et al. NAFLD polygenic risk score and risk of hepatocellular carcinoma in an East Asian population. Hepatol Commun. 2022;2022(9):2310\u201321. https:\/\/doi.org\/10.1002\/hep4.1976.","journal-title":"Hepatol Commun"},{"issue":"6","key":"779_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038322","volume":"7","author":"T Kawaguchi","year":"2012","unstructured":"Kawaguchi T, Sumida Y, Umemura A, et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One. 2012;7(6):e38322. https:\/\/doi.org\/10.1371\/journal.pone.0038322.","journal-title":"PLoS One"},{"issue":"7","key":"779_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00439-013-1294-3","volume":"132","author":"T Kitamoto","year":"2013","unstructured":"Kitamoto T, Kitamoto A, Yoneda M, et al. Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet. 2013;132(7):783\u201392. https:\/\/doi.org\/10.1007\/s00439-013-1294-3.","journal-title":"Hum Genet"},{"key":"779_CR18","doi-asserted-by":"publisher","unstructured":"Chung GE, Lee Y, Yim JY et al. Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population. Article. GUT AND LIVER. 2018 MAY 2018;12(3):316\u2013323. https:\/\/doi.org\/10.5009\/gnl17306","DOI":"10.5009\/gnl17306"},{"issue":"1","key":"779_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185490","volume":"13","author":"T Kawaguchi","year":"2018","unstructured":"Kawaguchi T, Shima T, Mizuno M, et al. Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. PLoS One. 2018;13(1):e0185490. https:\/\/doi.org\/10.1371\/journal.pone.0185490.","journal-title":"PLoS One"},{"issue":"8","key":"779_CR20","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/hep4.1533","volume":"4","author":"SL Park","year":"2020","unstructured":"Park SL, Li Y, Sheng X, et al. Genome-wide association study of liver fat: the multiethnic cohort adiposity phenotype study. Hepatol Commun. 2020;4(8):1112\u201323. https:\/\/doi.org\/10.1002\/hep4.1533.","journal-title":"Hepatol Commun"},{"key":"779_CR21","doi-asserted-by":"publisher","unstructured":"Chen Y, Du X, Kuppa A et al. Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. Nature Genetics. 2023-10 2023;55(10):1640\u20131650. https:\/\/doi.org\/10.1038\/s41588-023-01497-6","DOI":"10.1038\/s41588-023-01497-6"},{"issue":"2","key":"779_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/ajcn\/nqaa331","volume":"113","author":"L Wang","year":"2021","unstructured":"Wang L, Lee Y, Wu Y, et al. A prospective study of waist circumference trajectories and incident cardiovascular disease in China: the Kailuan cohort study. Am J Clin Nutr. 2021;113(2):338\u201347. https:\/\/doi.org\/10.1093\/ajcn\/nqaa331.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"779_CR23","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41596-020-0353-1","volume":"15","author":"SW Choi","year":"2020","unstructured":"Choi SW, Mak TS, O\u2019Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020;15(9):2759\u201372. https:\/\/doi.org\/10.1038\/s41596-020-0353-1.","journal-title":"Nat Protoc"},{"key":"779_CR24","doi-asserted-by":"publisher","unstructured":"Sollis E, Mosaku A, Abid A et al. The NHGRI-EBI GWAS catalog: knowledgebase and deposition resource. Nucleic Acids Res. 2023-01-06 2023;51(D1):D977\u201385. https:\/\/doi.org\/10.1093\/nar\/gkac1010","DOI":"10.1093\/nar\/gkac1010"},{"key":"779_CR25","unstructured":"Wells GA, Shea B, Peterson DOCJ, Welch V, Losos M. P Tugwell. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm"},{"issue":"5595","key":"779_CR26","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1126\/science.298.5595.941a","volume":"298","author":"J Couzin","year":"2002","unstructured":"Couzin J. Human genome. HapMap launched with pledges of $100 million. Science. 2002;298(5595):941\u20132.","journal-title":"Science"},{"key":"779_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.05.009","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhao X, Chen S, et al. Associations between nonalcoholic fatty liver disease and cancers in a large cohort in China. Clin Gastroenterol Hepatol. 2021. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.009.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"779_CR28","first-page":"393","volume":"31","author":"National Workshop on Fatty Liver and Alcoholic Liver Disease","year":"2018","unstructured":"National Workshop on Fatty Liver and Alcoholic Liver Disease. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. Zhonghua Gan Zang Bing Za Zhi. 2018;31(5):393\u2013420.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"779_CR29","doi-asserted-by":"publisher","unstructured":"Joint committee issued Chinese guideline for the management of dyslipidemia in adults. 2016 Chinese guideline for the management of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 2016-10-24 2016;44(10):833\u2013853. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-3758.2016.10.005","DOI":"10.3760\/cma.j.issn.0253-3758.2016.10.005"},{"key":"779_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49224-x","volume":"15","author":"SM Johnson","year":"2024","unstructured":"Johnson SM, Bao H, McMahon CE, et al. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein. Nat Commun. 2024;15:4847. https:\/\/doi.org\/10.1038\/s41467-024-49224-x.","journal-title":"Nat Commun"},{"issue":"1","key":"779_CR31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jhep.2017.02.014","volume":"67","author":"PK Luukkonen","year":"2017","unstructured":"Luukkonen PK, Zhou Y, Nidhina Haridas PA, et al. Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD. J Hepatol. 2017;67(1):128\u201336. https:\/\/doi.org\/10.1016\/j.jhep.2017.02.014.","journal-title":"J Hepatol"},{"key":"779_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101722","volume":"72","author":"BE Ford","year":"2023","unstructured":"Ford BE, Chachra SS, Rodgers K, et al. The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326. Mol Metab. 2023;72:101722. https:\/\/doi.org\/10.1016\/j.molmet.2023.101722.","journal-title":"Mol Metab"},{"key":"779_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8463640","volume":"2022","author":"G Li","year":"2022","unstructured":"Li G, Peng Y, Chen Z, Li H, Liu D, Ye X. Bidirectional association between hypertension and NAFLD: a systematic review and meta-analysis of observational studies. Int J Endocrinol. 2022;2022:8463640. https:\/\/doi.org\/10.1155\/2022\/8463640.","journal-title":"Int J Endocrinol"},{"issue":"9","key":"779_CR34","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/meg.0000000000001191","volume":"30","author":"D Oikonomou","year":"2018","unstructured":"Oikonomou D, Georgiopoulos G, Katsi V, et al. Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated? Eur J Gastroenterol Hepatol. 2018;30(9):979\u201385. https:\/\/doi.org\/10.1097\/meg.0000000000001191.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"779_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.13034","volume":"8","author":"R Hazzan","year":"2024","unstructured":"Hazzan R, Abu Ahmad N, Habib AS, Saleh I, Ziv N. Suboptimal reliability of FIB-4 and NAFLD-fibrosis scores for staging of liver fibrosis in general population. JGH Open. 2024;8(2):e13034. https:\/\/doi.org\/10.1002\/jgh3.13034.","journal-title":"JGH Open"},{"issue":"6","key":"779_CR36","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol"},{"issue":"2","key":"779_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.08.026","volume":"80","author":"H Hagstr\u00f6m","year":"2024","unstructured":"Hagstr\u00f6m H, Vessby J, Ekstedt M, Shang Y. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J Hepatol. 2024;80(2):e76\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.026.","journal-title":"J Hepatol"},{"issue":"2","key":"779_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.07.021","volume":"80","author":"SJ Song","year":"2024","unstructured":"Song SJ, Lai JC, Wong GL, Wong VW, Yip TC. Can we use old NAFLD data under the new MASLD definition? J Hepatol. 2024;80(2):e54. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.021.","journal-title":"J Hepatol"},{"issue":"3","key":"779_CR39","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 2011;54(3):1082\u201390. https:\/\/doi.org\/10.1002\/hep.24452.","journal-title":"Hepatology"},{"key":"779_CR40","doi-asserted-by":"publisher","unstructured":"Cherubini A, Rosso C, Della Torre S. Mar. Sex-specific effects of PNPLA3 I148M. Liver international: official journal of the international association for the study of the liver. 2025;45(3):e16088. https:\/\/doi.org\/10.1111\/liv.16088","DOI":"10.1111\/liv.16088"},{"issue":"4","key":"779_CR41","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457\u201369. https:\/\/doi.org\/10.1002\/hep.30626.","journal-title":"Hepatology"}],"container-title":["Genes & Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12263-025-00779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12263-025-00779-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12263-025-00779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:15:58Z","timestamp":1761898558000},"score":1,"resource":{"primary":{"URL":"https:\/\/genesandnutrition.biomedcentral.com\/articles\/10.1186\/s12263-025-00779-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1186\/s12263-025-00779-4","relation":{},"ISSN":["1555-8932","1865-3499"],"issn-type":[{"value":"1555-8932","type":"print"},{"value":"1865-3499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was based on a nested case\u2013control design within the Kailuan cohort and was registered in the Chinese Clinical Trial Registry (registration number: ChiCTR-TNRC-11001489). The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committees of Kailuan General Hospital and the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences. Written informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare that they have no competing financial interests or personal relationships that could influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}